Cargando…

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection

BACKGROUND: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) maintain undetectable viremia after treatment cessation. Associated factors remain unclear given the importance of the phenomenon to cure research. METHODS: Using CASCADE data of seroconverters startin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fidler, Sarah, Olson, Ashley D., Bucher, Heiner C., Fox, Julie, Thornhill, John, Morrison, Charles, Muga, Roberto, Phillips, Andrew, Frater, John, Porter, Kholoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2017
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228612/ https://www.ncbi.nlm.nih.gov/pubmed/27846036 http://dx.doi.org/10.1097/QAI.0000000000001220

Ejemplares similares

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

1573. Viral Blips While on Antiretroviral Therapy are Associated with Virologic Failure
por: Fleit, Madeline, et al.
Publicado: (2023)

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death
por: Olson, Ashley D., et al.
Publicado: (2016)

Predicting virological decay in patients starting combination antiretroviral therapy
Publicado: (2016)

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
por: Touloumi, Giota, et al.
Publicado: (2013)

A blip, but a very big blip, in test of atom-smasher
Publicado: (2008)

A blip, but a very big blip, in test of atom-smasher
Publicado: (2008)

Viral Blips Were Infrequent in HIV-1-Infected Virologically-Suppressed Adults Treated with Tenofovir Alafenamide or Tenofovir DF Rilpivirine-Containing Regimens
por: Wohl, David A, et al.
Publicado: (2017)

Brookhaven: BLIP and CLIF and MEIN
Publicado: (1976)

Factors Associated With Early Virological Response in HIV-Infected Individuals Starting Antiretroviral Therapy in Brazil (2014–2015): Results From a Large HIV Surveillance Cohort
por: Meireles, Mariana V., et al.
Publicado: (2018)

Immunologic and Virologic Progression in HIV Controllers: The Role of Viral “Blips” and Immune Activation in the ANRS CO21 CODEX Study
por: Noel, Nicolas, et al.
Publicado: (2015)

Brookhaven : BLIP, CLIF et MEIN
Publicado: (1976)

Tiny blip is a mighty feat
Publicado: (2008)

With PIPs, you get ZIPs and blips
por: Senning, Eric N.
Publicado: (2019)

Impact of CMV Blips in Transplant Recipients
por: Lodding, Isabelle Paula, et al.
Publicado: (2017)

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study
por: Caniglia, Ellen C., et al.
Publicado: (2016)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery
por: Thornhill, John Patrick, et al.
Publicado: (2017)

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients
por: Cooper, C, et al.
Publicado: (2015)

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4(+) T-cell recovery once HIV-1 suppression is achieved?
por: Jarrin, Inma, et al.
Publicado: (2015)

The Pandemic Holiday Blip in New York City
Publicado: (2021)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART
por: Vandormael, Alain M., et al.
Publicado: (2016)

With a blip, collider pushes physics into new phase
Publicado: (2008)

Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study
por: Castillo‐Mancilla, Jose R, et al.
Publicado: (2019)

Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women
por: Onoya, Dorina, et al.
Publicado: (2017)

CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
por: Martin, Genevieve E., et al.
Publicado: (2018)

Factors associated with HIV viral load “blips” and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case–control study
por: Farmer, Aaron, et al.
Publicado: (2016)

Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
por: Geretti, Anna Maria, et al.
Publicado: (2013)

Stop Selling and Start Leading
por: Kouzes, James
Publicado: (2018)

Stop lecturing and start teaching
Publicado: (2015)

Breast cancer incidence after the start of mammography screening in Denmark
por: Olsen, A H, et al.
Publicado: (2003)

Virological measures and factors associated with outcomes, and missing outcome data in HIV clinical trials: a methodological study
por: Youssef, Mark, et al.
Publicado: (2021)

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK
por: Inshaw, Jamie, et al.
Publicado: (2015)

Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion
por: Martin, Genevieve E, et al.
Publicado: (2020)

A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study
por: Fidler, Sarah, et al.
Publicado: (2017)

Substantial Heterogeneity in Progress Toward Reaching the 90-90-90 HIV Target in the WHO European Region
por: Porter, Kholoud, et al.
Publicado: (2018)

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection
por: Thornhill, John, et al.
Publicado: (2016)

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013)

The stop-start approach to rare isotopes
Publicado: (2008)

Epigenetic signatures of starting and stopping smoking
por: McCartney, Daniel L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k5uih7fmjju20o0j3pmdnrk6fe